{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T11:53:09Z","timestamp":1765972389914,"version":"3.48.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-04014-9","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T13:54:40Z","timestamp":1763128480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DNA methylation-mediated ADA overexpression drives pancreatic cancer progression"],"prefix":"10.1007","volume":"16","author":[{"given":"Jingyi","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juying","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hegen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"4014_CR1","unstructured":"Cancer of the Pancreas - Cancer Stat Facts. SEER. https:\/\/seer.cancer.gov\/statfacts\/html\/pancreas.html. Accessed 7 May 2024."},{"issue":"11","key":"4014_CR2","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of Thyroid, Liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913\u201321. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0155.","journal-title":"Cancer Res"},{"issue":"4","key":"4014_CR3","first-page":"346","volume":"26","author":"S Chakraborty","year":"2013","unstructured":"Chakraborty S, Singh S. Surgical resection improves survival in pancreatic cancer patients without vascular invasion- a population based study. Ann Gastroenterol. 2013;26(4):346\u201352.","journal-title":"Ann Gastroenterol"},{"key":"4014_CR4","doi-asserted-by":"publisher","first-page":"108748","DOI":"10.1016\/j.ejso.2024.108748","volume":"9","author":"G Goebel","year":"2024","unstructured":"Goebel G, Jooste V, Molinie F, et al. Surgical patterns of care of pancreatic cancer. A French population-based study. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 2024;9:108748. https:\/\/doi.org\/10.1016\/j.ejso.2024.108748.","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"12","key":"4014_CR5","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1038\/s41416-022-01752-3","volume":"126","author":"CJ Cabasag","year":"2022","unstructured":"Cabasag CJ, Arnold M, Rutherford M, et al. Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study. Br J Cancer. 2022;126(12):1774\u201382. https:\/\/doi.org\/10.1038\/s41416-022-01752-3.","journal-title":"Br J Cancer"},{"key":"4014_CR6","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff J, Korc M, Apte M, et al. Pancreatic cancer. Nat Rev Dis Primer. 2016;2:16022. https:\/\/doi.org\/10.1038\/nrdp.2016.22.","journal-title":"Nat Rev Dis Primer"},{"issue":"1","key":"4014_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1053\/j.gastro.2023.09.021","volume":"166","author":"Y Feng","year":"2024","unstructured":"Feng Y, Cai L, Pook M, et al. BRD9-SMAD2\/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma. Gastroenterology. 2024;166(1):139\u201354. https:\/\/doi.org\/10.1053\/j.gastro.2023.09.021.","journal-title":"Gastroenterology"},{"issue":"11","key":"4014_CR8","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula P, Del Greco MF, Pattaro C, K\u00f6ttgen A. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol JASN. 2016;27(11):3253\u201365. https:\/\/doi.org\/10.1681\/ASN.2016010098.","journal-title":"J Am Soc Nephrol JASN"},{"issue":"1","key":"4014_CR9","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","volume":"11","author":"AF Schmidt","year":"2020","unstructured":"Schmidt AF, Finan C, Gordillo-Mara\u00f1\u00f3n M, et al. Genetic drug target validation using Mendelian randomisation. Nat Commun. 2020;11(1):3255. https:\/\/doi.org\/10.1038\/s41467-020-16969-0.","journal-title":"Nat Commun"},{"issue":"8","key":"4014_CR10","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/d41573-022-00120-3","volume":"21","author":"D Ochoa","year":"2022","unstructured":"Ochoa D, Karim M, Ghoussaini M, Hulcoop DG, McDonagh EM, Dunham I. Human genetics evidence supports two-thirds of the 2021 FDA-approved drugs. Nat Rev Drug Discov. 2022;21(8):551\u2013551. https:\/\/doi.org\/10.1038\/d41573-022-00120-3.","journal-title":"Nat Rev Drug Discov"},{"key":"4014_CR11","doi-asserted-by":"publisher","first-page":"1441233","DOI":"10.3389\/fphar.2024.1441233","volume":"15","author":"Y Luan","year":"2024","unstructured":"Luan Y, Xian D, Zhao C, et al. Therapeutic targets for lung cancer: genome-wide Mendelian randomization and colocalization analyses. Front Pharmacol. 2024;15:1441233. https:\/\/doi.org\/10.3389\/fphar.2024.1441233.","journal-title":"Front Pharmacol"},{"issue":"1","key":"4014_CR12","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1186\/s12967-023-04474-z","volume":"21","author":"Y Cao","year":"2023","unstructured":"Cao Y, Yang Y, Hu Q, Wei G. Identification of potential drug targets for rheumatoid arthritis from genetic insights: a Mendelian randomization study. J Transl Med. 2023;21(1):616. https:\/\/doi.org\/10.1186\/s12967-023-04474-z.","journal-title":"J Transl Med"},{"issue":"1","key":"4014_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12931-024-02848-5","volume":"25","author":"Z Liu","year":"2024","unstructured":"Liu Z, Peng Z, Lin H, et al. Identifying potential drug targets for idiopathic pulmonary fibrosis: a Mendelian randomization study based on the druggable genes. Respir Res. 2024;25(1):217. https:\/\/doi.org\/10.1186\/s12931-024-02848-5.","journal-title":"Respir Res"},{"key":"4014_CR14","doi-asserted-by":"publisher","unstructured":"Vw S, Rc R, Bar W, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA. 2021;326(16). https:\/\/doi.org\/10.1001\/jama.2021.18236.","DOI":"10.1001\/jama.2021.18236"},{"issue":"383","key":"4014_CR15","doi-asserted-by":"publisher","first-page":"eaag1166","DOI":"10.1126\/scitranslmed.aag1166","volume":"9","author":"C Finan","year":"2017","unstructured":"Finan C, Gaulton A, Kruger FA, et al. The druggable genome and support for target identification and validation in drug development. Sci Transl Med. 2017;9(383):eaag1166. https:\/\/doi.org\/10.1126\/scitranslmed.aag1166.","journal-title":"Sci Transl Med"},{"issue":"11","key":"4014_CR16","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1038\/s41588-021-00954-4","volume":"53","author":"L Jiang","year":"2021","unstructured":"Jiang L, Zheng Z, Fang H, Yang J. A generalized linear mixed model association tool for biobank-scale data. Nat Genet. 2021;53(11):1616\u201321. https:\/\/doi.org\/10.1038\/s41588-021-00954-4.","journal-title":"Nat Genet"},{"issue":"7","key":"4014_CR17","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37(7):658\u201365. https:\/\/doi.org\/10.1002\/gepi.21758.","journal-title":"Genet Epidemiol"},{"issue":"4","key":"4014_CR18","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent Estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304\u201314. https:\/\/doi.org\/10.1002\/gepi.21965.","journal-title":"Genet Epidemiol"},{"issue":"2","key":"4014_CR19","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect Estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325. https:\/\/doi.org\/10.1093\/ije\/dyv080.","journal-title":"Int J Epidemiol"},{"issue":"6","key":"4014_CR20","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","volume":"46","author":"FP Hartwig","year":"2017","unstructured":"Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal Pleiotropy assumption. Int J Epidemiol. 2017;46(6):1985\u201398. https:\/\/doi.org\/10.1093\/ije\/dyx102.","journal-title":"Int J Epidemiol"},{"key":"4014_CR21","doi-asserted-by":"publisher","unstructured":"Mm ES, Mv G. Mendelian randomization. Nat Rev Methods Primer. 2022;2. https:\/\/doi.org\/10.1038\/s43586-021-00092-5.","DOI":"10.1038\/s43586-021-00092-5"},{"issue":"5","key":"4014_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-egger method. Eur J Epidemiol. 2017;32(5):377\u201389. https:\/\/doi.org\/10.1007\/s10654-017-0255-x.","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"4014_CR23","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1111\/rssb.12388","volume":"82","author":"G Wang","year":"2020","unstructured":"Wang G, Sarkar A, Carbonetto P, Stephens M. A simple new approach to variable selection in regression, with application to genetic fine mapping. J R Stat Soc Ser B Stat Methodol. 2020;82(5):1273\u2013300. https:\/\/doi.org\/10.1111\/rssb.12388.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"issue":"1","key":"4014_CR24","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1186\/s12885-024-12449-6","volume":"24","author":"W Song","year":"2024","unstructured":"Song W, Li Y, Yao Y, Sun S, Guan X, Wang B. Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer. BMC Cancer. 2024;24(1):680. https:\/\/doi.org\/10.1186\/s12885-024-12449-6.","journal-title":"BMC Cancer"},{"issue":"2","key":"4014_CR25","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/ije\/dyu176","volume":"44","author":"S Burgess","year":"2015","unstructured":"Burgess S, Daniel RM, Butterworth AS, Thompson SG, EPIC-InterAct Consortium. Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. Int J Epidemiol. 2015;44(2):484\u201395. https:\/\/doi.org\/10.1093\/ije\/dyu176.","journal-title":"Int J Epidemiol"},{"key":"4014_CR26","unstructured":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics - PubMed. Accessed September 29. 2024. https:\/\/pubmed.ncbi.nlm.nih.gov\/24830394\/"},{"issue":"5","key":"4014_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","volume":"48","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Zhang F, Hu H, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48(5):481\u20137. https:\/\/doi.org\/10.1038\/ng.3538.","journal-title":"Nat Genet"},{"key":"4014_CR28","doi-asserted-by":"publisher","unstructured":"Yin J, Ren W, Huang X, Deng J, Li T, Yin Y. Potential mechanisms connecting purine metabolism and cancer therapy. Front Immunol. 2018;9. https:\/\/doi.org\/10.3389\/fimmu.2018.01697.","DOI":"10.3389\/fimmu.2018.01697"},{"key":"4014_CR29","doi-asserted-by":"publisher","first-page":"155977","DOI":"10.1016\/j.cyto.2022.155977","volume":"158","author":"A Monroy-Mora","year":"2022","unstructured":"Monroy-Mora A, De Lourdes Mora-Garc\u00eda M, Alheli Monroy Mora K, et al. Inhibition of adenosine deaminase activity reverses resistance to the cytotoxic effect of high adenosine levels in cervical cancer cells. Cytokine. 2022;158:155977. https:\/\/doi.org\/10.1016\/j.cyto.2022.155977.","journal-title":"Cytokine"},{"issue":"5\u20136","key":"4014_CR30","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1159\/000108970","volume":"7","author":"M Ibi\u015f","year":"2007","unstructured":"Ibi\u015f M, K\u00f6kl\u00fc S, Yilmaz FM, et al. Serum adenosine deaminase levels in pancreatic diseases. Pancreatol Off J Int Assoc Pancreatol IAP Al. 2007;7(5\u20136):526\u201330. https:\/\/doi.org\/10.1159\/000108970.","journal-title":"Pancreatol Off J Int Assoc Pancreatol IAP Al"},{"key":"4014_CR31","doi-asserted-by":"publisher","first-page":"903461","DOI":"10.3389\/fimmu.2022.903461","volume":"13","author":"ZW Gao","year":"2022","unstructured":"Gao ZW, Yang L, Liu C, et al. Distinct roles of adenosine deaminase isoenzymes ADA1 and ADA2: A Pan-Cancer analysis. Front Immunol. 2022;13:903461. https:\/\/doi.org\/10.3389\/fimmu.2022.903461.","journal-title":"Front Immunol"},{"key":"4014_CR32","doi-asserted-by":"publisher","unstructured":"X LY, C T. CD26 as a promising biomarker for predicting prognosis in patients with pancreatic tumors. OncoTargets Ther. 2020;13. https:\/\/doi.org\/10.2147\/OTT.S278736.","DOI":"10.2147\/OTT.S278736"},{"key":"4014_CR33","doi-asserted-by":"publisher","first-page":"15677","DOI":"10.1007\/s13277-016-5315-4","volume":"37","author":"C Ye","year":"2016","unstructured":"Ye C, Tian X, Yue G, et al. Suppression of CD26 inhibits growth and metastasis of pancreatic cancer. Tumour Biol J Int Soc Oncodevelopmental Biol Med. 2016;37:15677\u201386. https:\/\/doi.org\/10.1007\/s13277-016-5315-4.","journal-title":"Tumour Biol J Int Soc Oncodevelopmental Biol Med"},{"issue":"1","key":"4014_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/med.21324","volume":"35","author":"A Cort\u00e9s","year":"2015","unstructured":"Cort\u00e9s A, Gracia E, Moreno E, et al. Moonlighting adenosine deaminase: a target protein for drug development. Med Res Rev. 2015;35(1):85\u2013125. https:\/\/doi.org\/10.1002\/med.21324.","journal-title":"Med Res Rev"},{"key":"4014_CR35","doi-asserted-by":"publisher","unstructured":"Moreno E, Canet J, Gracia E, et al. Molecular evidence of adenosine deaminase linking adenosine A2A receptor and CD26 proteins. Front Pharmacol. 2018;9. https:\/\/doi.org\/10.3389\/fphar.2018.00106.","DOI":"10.3389\/fphar.2018.00106"},{"issue":"20","key":"4014_CR36","doi-asserted-by":"publisher","first-page":"10991","DOI":"10.3390\/ijms252010991","volume":"25","author":"L Yang","year":"2024","unstructured":"Yang L, Qiao S, Zhang G, Lu A, Li F. Inflammatory processes: key mediators of oncogenesis and progression in pancreatic ductal adenocarcinoma (PDAC). Int J Mol Sci. 2024;25(20):10991. https:\/\/doi.org\/10.3390\/ijms252010991.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"4014_CR37","doi-asserted-by":"publisher","first-page":"5939","DOI":"10.1111\/jcmm.13864","volume":"22","author":"B Kutryb-Zajac","year":"2018","unstructured":"Kutryb-Zajac B, Koszalka P, Mierzejewska P, et al. Adenosine deaminase Inhibition suppresses progression of 4T1 murine breast cancer by adenosine receptor-dependent mechanisms. J Cell Mol Med. 2018;22(12):5939\u201354. https:\/\/doi.org\/10.1111\/jcmm.13864.","journal-title":"J Cell Mol Med"},{"key":"4014_CR38","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ebiom.2019.08.068","volume":"47","author":"D Yang","year":"2019","unstructured":"Yang D, Zhang Q, Ma Y, et al. Augmenting the therapeutic efficacy of adenosine against pancreatic cancer by switching the akt\/p21-dependent senescence to apoptosis. Ebiomedicine. 2019;47:114\u201327. https:\/\/doi.org\/10.1016\/j.ebiom.2019.08.068.","journal-title":"Ebiomedicine"},{"key":"4014_CR39","doi-asserted-by":"publisher","first-page":"bay141","DOI":"10.1093\/database\/bay141","volume":"2019","author":"R Kang","year":"2019","unstructured":"Kang R, Zhang Y, Huang Q, et al. EnhancerDB: a resource of transcriptional regulation in the context of enhancers. Database J Biol Databases Curation. 2019;2019:bay141. https:\/\/doi.org\/10.1093\/database\/bay141.","journal-title":"Database J Biol Databases Curation"},{"issue":"7414","key":"4014_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"ENCODE Project Consortium","year":"2012","unstructured":"ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57\u201374. https:\/\/doi.org\/10.1038\/nature11247.","journal-title":"Nature"},{"issue":"4","key":"4014_CR41","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/ng1051","volume":"32","author":"D Carter","year":"2002","unstructured":"Carter D, Chakalova L, Osborne CS, Dai Y, feng, Fraser P. Long-range chromatin regulatory interactions in vivo. Nat Genet. 2002;32(4):623\u20136. https:\/\/doi.org\/10.1038\/ng1051.","journal-title":"Nat Genet"},{"issue":"4","key":"4014_CR42","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","volume":"155","author":"D Hnisz","year":"2013","unstructured":"Hnisz D, Abraham BJ, Lee TI, et al. Super-enhancers in the control of cell identity and disease. Cell. 2013;155(4):934\u201347. https:\/\/doi.org\/10.1016\/j.cell.2013.09.053.","journal-title":"Cell"},{"issue":"4","key":"4014_CR43","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/bfgp\/elp016","volume":"8","author":"RJTS Palstra","year":"2009","unstructured":"Palstra RJTS. Close encounters of the 3\u00a0C kind: long-range chromatin interactions and transcriptional regulation. Brief Funct Genomic Proteomic. 2009;8(4):297\u2013309. https:\/\/doi.org\/10.1093\/bfgp\/elp016.","journal-title":"Brief Funct Genomic Proteomic"},{"issue":"17","key":"4014_CR44","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1101\/gad.399506","volume":"20","author":"E Splinter","year":"2006","unstructured":"Splinter E, Heath H, Kooren J, et al. CTCF mediates long-range chromatin looping and local histone modification in the beta-globin locus. Genes Dev. 2006;20(17):2349\u201354. https:\/\/doi.org\/10.1101\/gad.399506.","journal-title":"Genes Dev"},{"issue":"7","key":"4014_CR45","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2009.06.001","volume":"137","author":"JE Phillips","year":"2009","unstructured":"Phillips JE, Corces VG. CTCF: master weaver of the genome. Cell. 2009;137(7):1194\u2013211. https:\/\/doi.org\/10.1016\/j.cell.2009.06.001.","journal-title":"Cell"},{"issue":"34","key":"4014_CR46","doi-asserted-by":"publisher","first-page":"22507","DOI":"10.1074\/jbc.R109.019273","volume":"284","author":"Z Luka","year":"2009","unstructured":"Luka Z, Mudd SH, Wagner C. Glycine N-methyltransferase and regulation of S-adenosylmethionine levels. J Biol Chem. 2009;284(34):22507\u201311. https:\/\/doi.org\/10.1074\/jbc.R109.019273.","journal-title":"J Biol Chem"},{"issue":"1","key":"4014_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","volume":"25","author":"GS Ducker","year":"2017","unstructured":"Ducker GS, Rabinowitz JD. One-carbon metabolism in health and disease. Cell Metab. 2017;25(1):27\u201342. https:\/\/doi.org\/10.1016\/j.cmet.2016.08.009.","journal-title":"Cell Metab"},{"issue":"6","key":"4014_CR48","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrg816","volume":"3","author":"PA Jones","year":"2002","unstructured":"Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3(6):415\u201328. https:\/\/doi.org\/10.1038\/nrg816.","journal-title":"Nat Rev Genet"},{"issue":"9","key":"4014_CR49","doi-asserted-by":"publisher","first-page":"a019505","DOI":"10.1101\/cshperspect.a019505","volume":"8","author":"SB Baylin","year":"2016","unstructured":"Baylin SB, Jones PA. Epigenetic determinants of cancer. Cold Spring Harb Perspect Biol. 2016;8(9):a019505. https:\/\/doi.org\/10.1101\/cshperspect.a019505.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"4014_CR50","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000369674","volume":"35","author":"Y Nakajima","year":"2015","unstructured":"Nakajima Y, Kanno T, Nagaya T, et al. Adenosine deaminase inhibitor EHNA exhibits a potent anticancer effect against malignant pleural mesothelioma. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol. 2015;35(1):51\u201360. https:\/\/doi.org\/10.1159\/000369674.","journal-title":"Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol"},{"key":"4014_CR51","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.ijbiomac.2019.09.078","volume":"141","author":"S Bagheri","year":"2019","unstructured":"Bagheri S, Saboury AA, Haertl\u00e9 T. Adenosine deaminase Inhibition. Int J Biol Macromol. 2019;141:1246\u201357. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.09.078.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"4014_CR52","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.3390\/cancers6042137","volume":"6","author":"M Schober","year":"2014","unstructured":"Schober M, Jesenofsky R, Faissner R, et al. Desmoplasia and chemoresistance in pancreatic cancer. Cancers. 2014;6(4):2137\u201354. https:\/\/doi.org\/10.3390\/cancers6042137.","journal-title":"Cancers"},{"issue":"23","key":"4014_CR53","doi-asserted-by":"publisher","first-page":"6135","DOI":"10.3390\/cancers13236135","volume":"13","author":"TMA Carvalho","year":"2021","unstructured":"Carvalho TMA, Di Molfetta D, Greco MR, et al. Tumor microenvironment features and chemoresistance in pancreatic ductal adenocarcinoma: insights into targeting physicochemical barriers and metabolism as therapeutic approaches. Cancers. 2021;13(23):6135. https:\/\/doi.org\/10.3390\/cancers13236135.","journal-title":"Cancers"},{"issue":"5","key":"4014_CR54","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.ajhg.2022.04.001","volume":"109","author":"V Zuber","year":"2022","unstructured":"Zuber V, Grinberg NF, Gill D, et al. Combining evidence from Mendelian randomization and colocalization: review and comparison of approaches. Am J Hum Genet. 2022;109(5):767\u201382. https:\/\/doi.org\/10.1016\/j.ajhg.2022.04.001.","journal-title":"Am J Hum Genet"},{"key":"4014_CR55","doi-asserted-by":"publisher","first-page":"e21374","DOI":"10.7554\/eLife.21374","volume":"6","author":"S Monterisi","year":"2017","unstructured":"Monterisi S, Lobo MJ, Livie C, et al. PDE2A2 regulates mitochondria morphology and apoptotic cell death via local modulation of cAMP\/PKA signalling. eLife. 2017;6:e21374. https:\/\/doi.org\/10.7554\/eLife.21374.","journal-title":"eLife"},{"issue":"11","key":"4014_CR56","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1002\/2211-5463.13478","volume":"12","author":"J Zhang","year":"2022","unstructured":"Zhang J, Xiao J, Wang Y, Zheng X, Cui J, Wang C. A universal co-expression gene network and prognostic model for hepatic-biliary-pancreatic cancers identified by integrative analyses. FEBS Open Bio. 2022;12(11):2006\u201324. https:\/\/doi.org\/10.1002\/2211-5463.13478.","journal-title":"FEBS Open Bio"},{"key":"4014_CR57","doi-asserted-by":"publisher","first-page":"101005","DOI":"10.1016\/j.drup.2023.101005","volume":"71","author":"W Zhang","year":"2023","unstructured":"Zhang W, Fan Y, Zhang J, et al. Cell membrane-camouflaged Bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer. Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother. 2023;71:101005. https:\/\/doi.org\/10.1016\/j.drup.2023.101005.","journal-title":"Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother"},{"issue":"30","key":"4014_CR58","doi-asserted-by":"publisher","first-page":"7783","DOI":"10.1073\/pnas.1722056115","volume":"115","author":"E Bandala-Sanchez","year":"2018","unstructured":"Bandala-Sanchez E, Bediaga G, Goddard-Borger N. CD52 glycan binds the Proinflammatory B box of HMGB1 to engage the Siglec-10 receptor and suppress human T cell function. Proc Natl Acad Sci U S A. 2018;115(30):7783\u20138. https:\/\/doi.org\/10.1073\/pnas.1722056115.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"4014_CR59","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1586\/17474086.2015.1079123","volume":"8","author":"M Doubek","year":"2015","unstructured":"Doubek M, \u0160m\u00edda M. Treatment of chronic lymphocytic leukemia with monoclonal antibodies, where are we heading? Expert Rev Hematol. 2015;8(6):743\u201364. https:\/\/doi.org\/10.1586\/17474086.2015.1079123.","journal-title":"Expert Rev Hematol"},{"key":"4014_CR60","doi-asserted-by":"publisher","unstructured":"Cai Y, Zhao J, Luo C et al. CD52 knockdown inhibits aerobic glycolysis and malignant behavior of NSCLC cells through AKT signaling pathway. J Cancer. 2024;15(11):3394\u20133405. https:\/\/doi.org\/10.7150\/jca.86511.","DOI":"10.7150\/jca.86511"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04014-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-04014-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04014-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T11:28:08Z","timestamp":1765970888000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-04014-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4014"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-04014-9","relation":{},"ISSN":["2730-6011"],"issn-type":[{"type":"electronic","value":"2730-6011"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"23 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All human-related research procedures received approval from the pertinent institutional review boards, ensuring compliance with local regulations and institutional policies. Under the applicable national framework, there was no obligation for written informed consent from participants or their legally recognized proxies or relatives.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript has not been published previously in any form and submitted elsewhere for publication. All the authors involved have approved the manuscript and agree to submit to the journal Discover Oncology and agree with submission to your esteemed journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2203"}}